Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of LXRX will rise by +4.91% over the next 2 Weeks and hit $1.38 by Wednesday, March 4, 2026. In that time frame, LXRX's share price is expected to range between $1.19 and $1.59.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Mar 4, 2026 | 1.19 | 1.38 | 1.59 |
| Mar 3, 2026 | 1.16 | 1.36 | 1.57 |
| Mar 2, 2026 | 1.10 | 1.32 | 1.53 |
| Feb 27, 2026 | 1.14 | 1.33 | 1.53 |
| Feb 26, 2026 | 1.17 | 1.38 | 1.59 |
| Feb 25, 2026 | 1.18 | 1.36 | 1.57 |
| Feb 24, 2026 | 1.14 | 1.34 | 1.54 |
| Feb 23, 2026 | 1.09 | 1.29 | 1.48 |
| Feb 20, 2026 | 1.10 | 1.31 | 1.51 |
| Feb 19, 2026 | 1.15 | 1.35 | 1.56 |
LXRX shares rose +15.15% in Thursday, February 19, 2026's trading session, rising from a previous close of $1.32 to move at $1.52. The stock demonstrated notable intraday movement (see LXRX's key stats for a full breakdown), fluctuating between $1.40 and $1.52, a +8.57% trading range. While recent weeks have seen some volatility, LXRX has managed to secure a +28.81% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 3.34M shares changing hands, 1.81M more than the previous session. This amounted to $5.08M in total market activity.
Will LXRX Continue Its Upward Trend?
According to analyst ratings and projections for LXRX, Lexicon Pharmaceuticals, Inc. shares are anticipated to increase by +4.60%, potentially reaching $1.59 per share by March 4, 2026. Short-term technical indicators currently suggest a neutral sentiment for LXRX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 17 positive trading days within the past 30 sessions. Based on the LXRX stock forecast, now is a good time to buy LXRX stock because its current trading price is +9.76% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on LXRX covering social and institutional perspectives.
LXRX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into LXRX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 57.27% to 65.35%) suggest the stock is showing bullish momentum with some volatility. The 50-day RSI, at 53.95%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 52.84%, maintains a neutral outlook for the long term. Insights into LXRX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Lexicon Pharmaceuticals Short-Term Forecasts
LXRX Forecast For Next 5 Days
Our algorithm anticipates Lexicon Pharmaceuticals (LXRX) stock could hit $1.58 by Feb 26, 2026. This represents a +3.97% rise from today's price, following a +11.02% change over the past five days.
LXRX Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Lexicon Pharmaceuticals, Inc. (LXRX) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $1.35, which would mean a -11.18% decrease from the current price of $1.52. Projections for this period range from a high of $1.73 to a low of $1.10.
LXRX Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Lexicon Pharmaceuticals's price over the next three months point to a rise. LXRX stock is expected to peak at $13.24 on May 18, 2026 after potentially dipping to $7.41 on Apr 14, 2026. On average, LXRX is likely to trade around $9.64 in the coming 90 days.
Lexicon Pharmaceuticals Stock Forecast 2025
Based on our predictive models, Lexicon Pharmaceuticals (LXRX) is expected to trade between $7.41 and $25.30 throughout 2026. This would result in an average price of $13.78, potentially offering investors a +806.58% return from current levels.
Lexicon Pharmaceuticals, Inc. Monthly Forecast 2026–2027
February 2026
According to our latest forecast models, Lexicon Pharmaceuticals, Inc. (LXRX) is positioned to show a strong performance in February 2026. The price is predicted to move between $8.56 and $9.27, settling at an average of $8.83. This could translate to a +480.92% gain.
March 2026
Based on current market signals, Lexicon Pharmaceuticals, Inc. is projected to trend march 2026. We forecast a trading range from $8.01 to $10.21, with a likely average price of $9.19. Investors could expect a potential return of +504.61%.
April 2026
Our predictive algorithms indicate Lexicon Pharmaceuticals, Inc. stock may see a shift in April 2026. The expected range spans $7.41–$10.50, with an average target of $8.80. This represents a positive outlook and a possible gain of +478.95%.
May 2026
Analyzing established trends, Lexicon Pharmaceuticals, Inc. looks set to move in May 2026. Projections place the stock between $10.51 and $13.24, averaging around $12.27. This suggests a +707.24% gain from current levels.
June 2026
Market indicators suggest Lexicon Pharmaceuticals, Inc. could experience notable changes during June 2026. Prices could fluctuate within $11.03 to $14.20, with a midpoint forecast of $12.33. The stock might deliver a +711.18% gain.
July 2026
Forecasting for July 2026, models estimate that Lexicon Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $11.01 and $22.39, averaging $15.86. This signals a positive trajectory with potential returns around +943.42%.
August 2026
According to our latest forecast models, Lexicon Pharmaceuticals, Inc. (LXRX) is positioned to show a strong performance in August 2026. The price is predicted to move between $14.58 and $22.57, settling at an average of $17.69. This could translate to a +1,063.82% gain.
September 2026
Based on current market signals, Lexicon Pharmaceuticals, Inc. is projected to trend september 2026. We forecast a trading range from $15.21 to $22.95, with a likely average price of $17.64. Investors could expect a potential return of +1,060.53%.
October 2026
Our predictive algorithms indicate Lexicon Pharmaceuticals, Inc. stock may see a shift in October 2026. The expected range spans $16.50–$25.30, with an average target of $19.23. This represents a positive outlook and a possible gain of +1,165.13%.
November 2026
Analyzing established trends, Lexicon Pharmaceuticals, Inc. looks set to move in November 2026. Projections place the stock between $9.34 and $22.67, averaging around $14.32. This suggests a +842.11% gain from current levels.
December 2026
Market indicators suggest Lexicon Pharmaceuticals, Inc. could experience notable changes during December 2026. Prices could fluctuate within $8.97 to $19.95, with a midpoint forecast of $12.15. The stock might deliver a +699.34% gain.
January 2027
Forecasting for January 2027, models estimate that Lexicon Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $11.01 and $20.14, averaging $13.51. This signals a positive trajectory with potential returns around +788.82%.
February 2027
According to our latest forecast models, Lexicon Pharmaceuticals, Inc. (LXRX) is positioned to show a strong performance in February 2027. The price is predicted to move between $14.39 and $25.17, settling at an average of $16.94. This could translate to a +1,014.47% gain.
LXRX's history of dividends and stock splits also plays a role in long-term investor confidence.

